Business Description
Syn2bio SA
ISIN : PLSNBIO00013
Description
Syn2bio SA is a Polish biotech company that develops radiopharmaceuticals. It specializes in developing a cardiac biomarker for diagnosing heart conditions like coronary artery disease through myocardial perfusion imaging. The company's flagship product is the SYN2 cardiotracer. It is applied in the detection of perfusion disorders, evaluation of patients after myocardial infarction or with ischemic heart disease, and assessment of atherosclerotic changes in coronary arteries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 11.1 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 96.25 | |||||
9-Day RSI | 91.37 | |||||
14-Day RSI | 87.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.83 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -133.21 | |||||
ROA % | -101.98 | |||||
ROIC % | -145.23 | |||||
ROC (Joel Greenblatt) % | -900.61 | |||||
ROCE % | -156.29 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 42.62 | |||||
Price-to-Tangible-Book | 42.62 | |||||
EV-to-EBIT | -24.34 | |||||
EV-to-EBITDA | -24.85 | |||||
EV-to-FCF | -32.76 | |||||
Earnings Yield (Greenblatt) % | -4.11 | |||||
FCF Yield % | -2.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syn2bio SA Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | |||
| EPS (TTM) (zł) | -2.711 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 87.06 | ||
| 14-Day ATR (zł) | 6.832353 | ||
| 20-Day SMA (zł) | 51.473 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (zł) | 26.2 - 96.6 | ||
| Shares Outstanding (Mil) | 8.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syn2bio SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syn2bio SA Stock Events
| Event | Date | Price (zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Syn2bio SA Frequently Asked Questions
What is Syn2bio SA(WAR:S2B)'s stock price today?
The current price of WAR:S2B is zł81.40. The 52 week high of WAR:S2B is zł96.60 and 52 week low is zł26.20.
When is next earnings date of Syn2bio SA(WAR:S2B)?
The next earnings date of Syn2bio SA(WAR:S2B) is .
Does Syn2bio SA(WAR:S2B) pay dividends? If so, how much?
Syn2bio SA(WAR:S2B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Syn2bio SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers